CI&T (NYSE:CINT) versus ChronoScale Corporation Common Stock (NASDAQ:CHRN) Critical Comparison

ChronoScale Corporation Common Stock (NASDAQ:CHRNGet Free Report) and CI&T (NYSE:CINTGet Free Report) are both small-cap technology companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.

Analyst Recommendations

This is a summary of recent recommendations and price targets for ChronoScale Corporation Common Stock and CI&T, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
ChronoScale Corporation Common Stock 1 1 0 0 1.50
CI&T 2 2 7 0 2.45

ChronoScale Corporation Common Stock presently has a consensus price target of $6.00, indicating a potential downside of 72.76%. CI&T has a consensus price target of $6.41, indicating a potential upside of 91.66%. Given CI&T’s stronger consensus rating and higher probable upside, analysts plainly believe CI&T is more favorable than ChronoScale Corporation Common Stock.

Earnings and Valuation

This table compares ChronoScale Corporation Common Stock and CI&T”s top-line revenue, earnings per share (EPS) and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
ChronoScale Corporation Common Stock $12.80 million 6.13 -$11.69 million ($5.38) -4.09
CI&T $489.65 million 0.92 $40.62 million $0.31 10.79

CI&T has higher revenue and earnings than ChronoScale Corporation Common Stock. ChronoScale Corporation Common Stock is trading at a lower price-to-earnings ratio than CI&T, indicating that it is currently the more affordable of the two stocks.

Volatility and Risk

ChronoScale Corporation Common Stock has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. Comparatively, CI&T has a beta of 0.81, meaning that its stock price is 19% less volatile than the S&P 500.

Profitability

This table compares ChronoScale Corporation Common Stock and CI&T’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
ChronoScale Corporation Common Stock -135.66% -197.81% -74.17%
CI&T 7.90% 13.19% 7.32%

Institutional and Insider Ownership

6.4% of ChronoScale Corporation Common Stock shares are owned by institutional investors. Comparatively, 92.4% of CI&T shares are owned by institutional investors. 6.9% of ChronoScale Corporation Common Stock shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Summary

CI&T beats ChronoScale Corporation Common Stock on 11 of the 14 factors compared between the two stocks.

About ChronoScale Corporation Common Stock

(Get Free Report)

Ekso Bionics Holdings, Inc. designs, develops, sells, and rents exoskeleton products in the Americas, Germany, Poland, Europe, the Middle East, Africa, the Asia Pacific, and internationally. It operates in two segments, EksoHealth and EksoWorks. The EksoHealth segment designs, engineers, manufactures, and markets exoskeletons for applications in the medical markets. The EksoWorks segment designs, engineers, manufactures, and markets exoskeleton devices to allow able-bodied users to perform difficult repetitive work for extended periods. The company provides EksoNR, a wearable bionic suit and rehabilitation device that assists physical therapists and physicians to treat patients with acquired brain injury, stroke, and spinal cord injury; Ekso Indego Therapy, an adjustable and lower-limb powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; Ekso Nomad, a power knee ankle foot orthosis; and Ekso EV, a wearable upper body exoskeleton that elevates and supports a worker's arms to assist with tasks from chest height to overhead. Ekso Bionics Holdings, Inc. was founded in 2005 and is headquartered in San Rafael, California.

About CI&T

(Get Free Report)

CI&T, Inc. provides strategy, design and software engineering services to enable digital transformation. The firm’s solutions and services include Digital Strategy, Customer-Centric Design and Top-of-the-Line Software Engineering. The company was founded by Cesar Nivaldo Gon, Bruno GuiƧardi Neto and Fernando Matt Borges Martins on June 7, 2021 and is headquartered in Sao Paulo, Brazil.

Receive News & Ratings for ChronoScale Corporation Common Stock Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ChronoScale Corporation Common Stock and related companies with MarketBeat.com's FREE daily email newsletter.